Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Regression of severe pulmonary arteriovenous malformations after Fontan revision and "Hepatic factor" rerouting ANNALS OF THORACIC SURGERY Pike, N. A., Vricella, L. A., Feinstein, J. A., Black, M. D., Reitz, B. A. 2004; 78 (2): 697-699

Abstract

Although previously described in patients undergoing staged palliation for univentricular heart disease, the mechanism by which hepatic venous flow prevents development of pulmonary arteriovenous malformations is still not completely understood. We present a case in which successful H-type Fontan revision with rerouting of hepatic venous flow through a hemiazygous vein successfully reversed the progression of severe left pulmonary arteriovenous malformations.

View details for DOI 10.1016/j.athorascur.2004.02.003

View details for Web of Science ID 000222999300055

View details for PubMedID 15276554